Compared to hypofractionated radiotherapy, SBRT improves short-term but not long-term QoL in patients with inoperable stage I ...
A majority — eight members — voted that women who have tested negative for hepatitis B should consult with clinicians on when ...
The results of the 2025 Medicine and Pediatric Specialties Match followed the same patterns seen in recent years for both ...
Dr S. Shahzad Mustafa discusses three FDA approved medications for chronic spontaneous urticaria and the need to tailor ...
Advocacy is needed now more than ever to improve pediatric care, particularly for subspecialties like rheumatology, given all the pressures accumulating on the field, Dr Madelaine Feldman writes.
Lisocabtagene maraleucel (liso-cel) is now the only CD19-directed chimeric antigen receptor (CAR) T-cell therapy approved for MZL. The approval marks liso-cel’s fifth indication, the most of any ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback